Literature DB >> 2812855

Altered autonomic function in patients with arthritis or with chronic myofascial pain.

Franklin Perry1, Philip H Heller, Joe Kamiya, Jon D Levine.   

Abstract

Dynamic autonomic function tests (pupillary light reflex, Valsalva maneuver, and mental arithmetic) were used to evaluate autonomic function (pupil size, heart rate, and skin conductance) in patients with inflammatory arthritis or with chronic myofascial pain. Physiological responses in both groups of patients suggest concurrent increases in tonic pupillary autonomic activity (sympathetic and parasympathetic), with a relative sympathetic dominance, and a decrease in tonic parasympathetic cardiovascular activity. Furthermore, in the arthritis group, the data suggest decreased cardiovascular parasympathetic reaction and enhanced sudomotor reaction.

Entities:  

Mesh:

Year:  1989        PMID: 2812855     DOI: 10.1016/0304-3959(89)90177-2

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  29 in total

1.  Potential autonomic risk factors for chronic TMD: descriptive data and empirically identified domains from the OPPERA case-control study.

Authors:  William Maixner; Joel D Greenspan; Ronald Dubner; Eric Bair; Flora Mulkey; Vanessa Miller; Charles Knott; Gary D Slade; Richard Ohrbach; Luda Diatchenko; Roger B Fillingim
Journal:  J Pain       Date:  2011-11       Impact factor: 5.820

2.  Increased aggregation response of platelets in patients with inflammatory bowel disease.

Authors:  Akira Andoh; Takashi Yoshida; Yuki Yagi; Shigeki Bamba; Kazunori Hata; Tomoyuki Tsujikawa; Katsuyuki Kitoh; Masaya Sasaki; Yoshihide Fujiyama
Journal:  J Gastroenterol       Date:  2006-01       Impact factor: 7.527

3.  Cardiovascular responses to an acute psychological stressor are associated with the cortisol awakening response in individuals with chronic neck pain.

Authors:  Bahar Shahidi; Timothy Sannes; Mark Laudenslager; Katrina S Maluf
Journal:  Physiol Behav       Date:  2015-02-07

Review 4.  Sympathetic modulation of immunity: relevance to disease.

Authors:  Denise L Bellinger; Brooke A Millar; Sam Perez; Jeff Carter; Carlo Wood; Srinivasan ThyagaRajan; Christine Molinaro; Cheri Lubahn; Dianne Lorton
Journal:  Cell Immunol       Date:  2008-03-04       Impact factor: 4.868

5.  Adrenergic dysregulation and pain with and without acute beta-blockade in women with fibromyalgia and temporomandibular disorder.

Authors:  Kathleen C Light; Edith E Bragdon; Karen M Grewen; Kimberly A Brownley; Susan S Girdler; William Maixner
Journal:  J Pain       Date:  2009-05       Impact factor: 5.820

6.  Drug-disease interaction: Crohn's disease elevates verapamil plasma concentrations but reduces response to the drug proportional to disease activity.

Authors:  Forough Sanaee; John D Clements; Alistair W G Waugh; Richard N Fedorak; Richard Lewanczuk; Fakhreddin Jamali
Journal:  Br J Clin Pharmacol       Date:  2011-11       Impact factor: 4.335

7.  Parasympathetic dysfunction in rheumatoid arthritis patients with ocular dryness.

Authors:  P J Barendregt; G L van der Heijde; F C Breedveld; H M Markusse
Journal:  Ann Rheum Dis       Date:  1996-09       Impact factor: 19.103

8.  Biopsychosocial influence on shoulder pain: Rationale and protocol for a pre-clinical trial.

Authors:  Steven Z George; Roland Staud; Paul A Borsa; Samuel S Wu; Margaret R Wallace; Warren H Greenfield; Lauren N Mackie; Roger B Fillingim
Journal:  Contemp Clin Trials       Date:  2017-03-14       Impact factor: 2.226

9.  Chronic pain and cardiovascular stress responses in a general population: the Tromsø Study.

Authors:  Roy Bjørkholt Olsen; Stephen Bruehl; Christopher Sivert Nielsen; Leiv Arne Rosseland; Anne Elise Eggen; Audun Stubhaug
Journal:  J Behav Med       Date:  2014-05-03

10.  Persistent Catechol-O-methyltransferase-dependent Pain Is Initiated by Peripheral β-Adrenergic Receptors.

Authors:  Brittney P Ciszek; Sandra C O'Buckley; Andrea G Nackley
Journal:  Anesthesiology       Date:  2016-05       Impact factor: 7.892

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.